Jazz Pharmaceuticals says data from its Phase 2b clinical trial evaluating the efficacy and safety of suvecaltamide in adult patients with essential t...
Johnson & Johnson asks FDA to approve a new indication for its Tremfya to treat some adults with Crohns disease.
FDA grants Onkos Surgical a de novo authorization for its novel antibacterial coating for use with implants.
FDA approves a new ulcerative colitis indication for AbbVies Skyrizi.
Federal Register notice: FDA corrects a 3/29 notice on the approval withdrawals of 30 ANDAs from multiple applicants due to Target Healths notificatio...
FDA publishes a guidance explaining how CVM assesses human user safety in applicable animal drug applications.
FDA tells NDA and ANDA sponsors they must repeat clinical and bioanalytical studies conducted for their applications by Synapse Labs in Pune, India, d...
Six stakeholders express appreciation for and suggest improvements to an FDA draft guidance on using real-world evidence in non-interventional studies...
